Humana Inc. (NYSE:HUM) shares saw an uptick in trading volume on Monday . 4,806,283 shares changed hands during mid-day trading, an increase of 38% from the previous session’s volume of 3,482,813 shares.The stock last traded at $153.87 and had previously closed at $158.15.

A number of brokerages have commented on HUM. Cantor Fitzgerald reiterated a “buy” rating on shares of Humana in a research note on Saturday. Morgan Stanley reiterated a “hold” rating on shares of Humana in a research note on Sunday, May 22nd. Stifel Nicolaus increased their price target on shares of Humana from $209.00 to $220.00 and gave the company a “buy” rating in a research note on Thursday, May 5th. Royal Bank Of Canada increased their price target on shares of Humana from $209.00 to $220.00 and gave the company a “sector perform” rating in a research note on Thursday, May 5th. Finally, Credit Suisse Group AG reiterated a “hold” rating on shares of Humana in a research note on Thursday, May 5th. One research analyst has rated the stock with a sell rating, seven have assigned a hold rating and four have given a buy rating to the stock. The company has a consensus rating of “Hold” and an average target price of $206.00.

The firm has a 50 day moving average of $180.14 and a 200 day moving average of $175.34. The firm has a market capitalization of $22.95 billion and a price-to-earnings ratio of 21.47.

Humana (NYSE:HUM) last issued its quarterly earnings results on Wednesday, May 4th. The insurance provider reported $1.86 EPS for the quarter, beating analysts’ consensus estimates of $1.81 by $0.05. During the same quarter in the previous year, the business earned $2.58 earnings per share. The business had revenue of $13.80 billion for the quarter, compared to the consensus estimate of $13.80 billion. The firm’s revenue was down .2% on a year-over-year basis. On average, equities analysts expect that Humana Inc. will post $8.87 earnings per share for the current fiscal year.

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 29th. Shareholders of record on Thursday, June 30th will be given a dividend of $0.29 per share. This represents a $1.16 dividend on an annualized basis and a yield of 0.75%. The ex-dividend date of this dividend is Tuesday, June 28th.

A number of hedge funds and institutional investors have modified their holdings of HUM. Wellington Shields Capital Management LLC boosted its position in shares of Humana by 17.1% in the fourth quarter. Wellington Shields Capital Management LLC now owns 5,935 shares of the insurance provider’s stock worth $1,059,000 after buying an additional 865 shares during the last quarter. Commerzbank Aktiengesellschaft FI boosted its position in shares of Humana by 52.0% in the fourth quarter. Commerzbank Aktiengesellschaft FI now owns 8,869 shares of the insurance provider’s stock worth $1,583,000 after buying an additional 3,035 shares during the last quarter. Tredje AP fonden boosted its position in shares of Humana by 1.7% in the fourth quarter. Tredje AP fonden now owns 9,477 shares of the insurance provider’s stock worth $1,694,000 after buying an additional 158 shares during the last quarter. Gamco Investors INC. ET AL boosted its position in shares of Humana by 12.1% in the fourth quarter. Gamco Investors INC. ET AL now owns 9,620 shares of the insurance provider’s stock worth $1,717,000 after buying an additional 1,040 shares during the last quarter. Finally, Deere & Co. boosted its position in shares of Humana by 791.1% in the fourth quarter. Deere & Co. now owns 10,078 shares of the insurance provider’s stock worth $1,799,000 after buying an additional 8,947 shares during the last quarter.

Humana Inc is a health and well-being company. The Company’s segments include Retail, Group, Healthcare Services and Other Businesses. The Retail segment consists of Medicare benefits, marketed to individuals or directly via group accounts, as well as individual commercial fully-insured medical and specialty health insurance benefits, including dental, vision, and other supplemental health and financial protection products.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.